Dr. Vijay Palwe

Dr. Vijay Palwe is a radiation oncologist with 16 years of experience in managing malignant and benign tumours, as well as oncological emergencies. He is well trained in multiple radiotherapy techniques. He has also completed a training program in Tomotherapy at Clinica Luganese in Lugano, Switzerland in June 2017. Dr. Vijay's approach to treatment is one of a compassionate and patient-centered approach, with the aim to deliver the best possible outcome for each individual patient.

• Prevalence of molecular subtypes of breast cancer: a single institutional experience of 2062 patients (2020). European journal of breast health, 16(1), 39.
• Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial (2019). Oncotarget, 10(54), 5605.              
• The predictive role of neutrophil-to-lymphocyte ratio in the outcomes of patients with sarcomatoid carcinoma of oral cavity (2021). European Archives of Oto-Rhino-Laryngology, 1-9.
• Factors influencing non-adherence to radiotherapy: a retrospective audit of 1,548 patients from a tertiary cancer centre (2020). Journal of Radiotherapy in Practice, 19(4), 359-364.
• Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience (2021).
• European Journal of Breast Health, 17(1), 62.